Medicine Branch
Bethesda, Maryland 20892
0 studies enrolling now · 32 studies all time
What they study most
Adenocarcinoma of the Prostate, Bladder Cancer, Bone Metastases, Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Epidemic Kaposi's Sarcoma, Esophageal Cancer, Extensive Stage Small Cell Lung Cancer, Fallopian Tube Cancer, Gastric Cancer
Studies at this site
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer — Stopped early
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer — Completed
- Vaccine Therapy in Treating Patients With Multiple Myeloma — Completed
- BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy — Completed
- Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma — Completed
- Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer — Completed
- Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
- Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma — Completed
- Immunotoxin in Treating Patients With Leukemia or Lymphoma — Completed
- Depsipeptide in Treating Patients With Solid Tumors — Completed
- Flavopiridol in Treating Patients With Refractory Cancer — Completed
- Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy — Completed
- LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors — Completed
- Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma — Completed
- 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents — Completed
- Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus — Stopped early
- Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix — Completed
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
- Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
- Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum — Completed
- Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
- Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer — Completed
- Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection — Completed
- Raloxifene in Preventing Breast Cancer in Premenopausal Women — Completed
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Completed
- Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
- Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
- Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer — Completed
- Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early
- Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer — Completed